Stock Overview

Titan Biotech Share Price

Titan Biotech Share Price

421.1
+6.20 (1.49%)
28 Jul, 2026 • 03:20 PM
BSE: 524717 | Pharmaceuticals | Small Cap

Titan Biotech Annualised Returns

1 Year

372.30%Increase

3 Years

102.53%Increase

5 Years

44.14%Increase

10 Years

51.23%Increase

Titan Biotech Share Price Today


As of 28 Jul 2026, Titan Biotech share price is ₹426. The stock opened at ₹414.9 and had closed at ₹414.9 the previous day. During today’s trading session, Titan Biotech share price moved between ₹410.25 and ₹432.00, with an average price for the day of ₹421.13. Over the last 52 weeks, the stock has recorded a low of ₹82.31 and a high of ₹555.65. In terms of performance, Titan Biotech share price has increased by 118% over the past six months and has increased by 372.30% over the last year.

Titan Biotech Stock Performance

1W Return-1.77%
1M Return6.06%
6M Return112.77%
1Y Return378.14%
3Y Return699.96%
Today's High₹432
Today's Low₹410.25
52-Week High₹555.65
52-Week Low₹82.31
Prev. Close₹414.90
Open₹414.90
Face Value₹2
Mkt Cap (Cr.)₹1,714
PE Ratio62.48

Titan Biotech Share Price Chart

Titan Biotech Company background

Founded in: 1992
Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food water, tissue culture laboratories and in the departments of microbiology botony in medical colleges/universities.The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.During 200607, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 200910.The Company has already started modernization of its existing plant, Building at Bhiwadi, Rajasthan for meeting international standards and quality improvement. With improvement in Building and Modernisation of Existing Plant, Company will be able to cater the needs of its customers in a better way and provide high quality products meeting international standards to its domestic as well as overseas customers.

Titan Biotech Financial Highlights


For the full year FY2026–2027, revenue reached ₹211.6 crore and profit touched at ₹27.45 crore.
Titan Biotech SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 10,90,151 in 5 years with a gain of 7,90,151 (+263.38%)

Titan Biotech Fundamental

Market Cap (in crs)

1,714.30

Face Value

2

Turnover (in lacs)

125.10

Key Metrics

Qtr Change %
417.56% Gain from 52W Low
-9
Dividend yield 1yr %
Low in industry
0.1

Titan Biotech Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...

Titan Biotech Result Highlights

  • Titan Biotech reported a 11.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 39.4%.
  • Its expenses for the quarter were down by 13.9% QoQ and up 29.0% YoY.
  • The net profit decreased 21.1% QoQ and increased 66.2% YoY.
  • The earnings per share (EPS) of Titan Biotech stood at 1.63 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Titan Biotech Technical Analysis

Moving Averages Analysis
421.1
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
418.50
10 EMA
416.40
12 EMA
415.40
20 EMA
414.20
26 EMA
415.10
50 EMA
417.10
100 EMA
394.50
200 EMA
334.00
Delivery & Volume
Loading chart...

Day

100.00%

Week

100.00%

Month

100.00%

Delivery & Volume

418.67
Pivot
Resistance
First Resistance
426.23
Second Resistance
437.57
Third Resistance
445.13
Support
First Support
407.33
Second support
399.77
Third Support
388.43
Relative Strength Index
49.77
Money Flow Index
66.62
MACD
0.28
MACD Signal
-2.88
Average True Range
20.84
Average Directional Index
13.70
Rate of Change (21)
4.50
Rate of Change (125)
114.75
Compare

Titan Biotech Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
55.8%
Public
44.2%

Titan Biotech Latest News

06 JUL 2026
25 JUN 2026
23 JUN 2026

You can easily buy Titan Biotech shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Titan Biotech share price is ₹555.65 and ₹82.31 as of 28/7/2026.

Please be aware that Titan Biotech stock prices are subject to continuous fluctuations due to various factors.